MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$612.33
−0.46%Forward multiples
Based on analyst estimates
- P/E forward
- 33.32x
- P/E 2026E
- 34.78x
- P/E 2027E
- 31.64x
- P/E 2028E
- 28.48x
- P/S forward
- 5.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.21x
- PEG TTM
- 6.21x
- Price / book
- 39.39x
- Price / sales
- 6.14x
- Price / cash flow
- 22.71x
Enterprise value
- Enterprise value
- $16.7B
- EV / sales
- 6.01x
- EV / EBITDA
- 27.75x
- EV / EBIT
- 28.64x
- Market cap
- $17.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026